Company profile: Translate Bio
1.1 - Company Overview
Company description
- Provider of biotechnology-driven RNA therapeutics focused on rare diseases, developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Translate Bio
OralDNA Labs
HQ: United States
Website
- Description: Provider of salivary diagnostics services to treat, heal, and inspire oral health, offering a wide range of tests including DNA polymerase chain reaction (PCR) and next-generation sequencing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full OralDNA Labs company profile →
Pivot Bio
HQ: United States
Website
- Description: Provider of microbial nitrogen solutions for crop nutrition, including Pivot Bio PROVEN® 40 for corn and RETURN® for wheat and small grains, delivering steady nitrogen at the root on-seed or in-furrow; the N-OVATOR™ program that rewards reduced synthetic fertilizer use; and NLIGHTEN®, an in-furrow tank system for precise microbial nitrogen delivery with equipment reimbursement.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pivot Bio company profile →
Redpin Therapeutics
HQ: United States
Website
- Description: Provider of a preclinical-stage gene therapy platform developing proprietary chemogenetics for targeted cell therapies to address currently intractable diseases of the nervous system, integrating principles from synthetic biology, gene therapy, and traditional pharmacotherapy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Redpin Therapeutics company profile →
Lifecode Health
HQ: United States
Website
- Description: Provider of patient-specific molecular information to improve patient lives, amid the growing accessibility of molecular tumor profiling and the challenge of analyzing and interpreting the expanding genomic and therapeutic data from next-generation sequencing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lifecode Health company profile →
Verve Therapeutics
HQ: United States
Website
- Description: Provider of clinical-stage genetic medicines for cardiovascular disease, including gene editing therapies VERVE-101 targeting PCSK9 to lower LDL-C in heterozygous familial hypercholesterolemia and ASCVD, and VERVE-201 targeting ANGPTL3 for homozygous and refractory hypercholesterolemia, enabled by a proprietary GalNAc-LNP liver delivery system, with medicines evaluated in clinical trials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Verve Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Translate Bio
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Translate Bio
2.2 - Growth funds investing in similar companies to Translate Bio
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Translate Bio
4.2 - Public trading comparable groups for Translate Bio
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →